Myocardial beta-adrenergic receptor function during the development of pacing-induced heart failure.
暂无分享,去创建一个
S. Vatner | D. Cohen | D. Vatner | R. Shannon | K. Komamura | C. Homcy | C. Bianchi | K. Kiuchi | D. Cohen | Richard P. Shannon | Kazuo Komamura | Cesario Bianchi
[1] T Ihara,et al. Alterations in left ventricular diastolic function in conscious dogs with pacing-induced heart failure. , 1992, The Journal of clinical investigation.
[2] J. Liao,et al. Specific receptor-guanine nucleotide binding protein interaction mediates the release of endothelium-derived relaxing factor. , 1992, Circulation research.
[3] W. Schmitz,et al. Increased messenger RNA level of the inhibitory G protein alpha subunit Gi alpha-2 in human end-stage heart failure. , 1992, Circulation research.
[4] C M Bloor,et al. Myocardial,β‐Adrenergic Receptor Expression and Signal Transduction After Chronic Volume‐Overload Hypertrophy and Circulatory Congestion , 1992, Circulation.
[5] P. Molinoff,et al. Beta-adrenergic receptor-G protein-adenylate cyclase complex in experimental canine congestive heart failure produced by rapid ventricular pacing. , 1991, Circulation research.
[6] J. Rouleau,et al. Dysfunction of the beta- and alpha-adrenergic systems in a model of congestive heart failure. The pacing-overdrive dog. , 1991, Circulation research.
[7] S. Vatner,et al. Alterations in myocardial contractility in conscious dogs with dilated cardiomyopathy. , 1991, The American journal of physiology.
[8] K. Jakobs,et al. Increase of Gi alpha in human hearts with dilated but not ischemic cardiomyopathy. , 1990, Circulation.
[9] J. Port,et al. Beta-adrenergic pathways in nonfailing and failing human ventricular myocardium. , 1990, Circulation.
[10] Daly Pa,et al. Myocardial catecholamines and the pathophysiology of heart failure. , 1990 .
[11] M. Packer,et al. Role of the sympathetic nervous system in chronic heart failure. A historical and philosophical perspective. , 1990, Circulation.
[12] N. Heitkamp,et al. SAS system for elementary statistical analysis , 1990 .
[13] M. Michel,et al. Myocardial beta-adrenoceptor changes in heart failure: concomitant reduction in beta 1- and beta 2-adrenoceptor function related to the degree of heart failure in patients with mitral valve disease. , 1989, Journal of the American College of Cardiology.
[14] J. Saffitz,et al. Distribution of beta-adrenergic receptors in failing human myocardium. Implications for mechanisms of down-regulation. , 1989, Circulation.
[15] J. Gordon,et al. Beta-adrenergic receptor number and adenylate cyclase function in denervated transplanted and cardiomyopathic human hearts. , 1989, Circulation.
[16] G. Norbiato,et al. Identification of alpha 1-adrenergic receptors on sarcolemma from normal subjects and patients with idiopathic dilated cardiomyopathy: characteristics and linkage to GTP-binding protein. , 1989, Circulation research.
[17] W. Baumgartner,et al. Increase of the 40,000-mol wt pertussis toxin substrate (G protein) in the failing human heart. , 1988, The Journal of clinical investigation.
[18] C. Liang,et al. Alterations in cardiac β-adrenoceptor responsiveness and adenylate cyclase system by congestive heart failure in dogs , 1987 .
[19] M. Creager,et al. Baroreceptor function in congestive heart failure: effect on neurohumoral activation and regional vascular resistance. , 1987, Circulation.
[20] M. Bristow,et al. Assessment of the beta-adrenergic receptor pathway in the intact failing human heart: progressive receptor down-regulation and subsensitivity to agonist response. , 1986, Circulation.
[21] S. Jamieson,et al. Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure. , 1986, Circulation research.
[22] S. Vatner,et al. Loss of high affinity cardiac beta adrenergic receptors in dogs with heart failure. , 1985, The Journal of clinical investigation.
[23] David R. Sibley,et al. Molecular mechanisms of receptor desensitization using the β-adrenergic receptor-coupled adenylate cyclase system as a model , 1985, Nature.
[24] A. Spiegel,et al. The inhibitory adenylate cyclase coupling protein in pseudohypoparathyroidism. , 1985, The Journal of clinical endocrinology and metabolism.
[25] N. Kantrowitz,et al. Beta-adrenergic function in heart muscle disease and heart failure. , 1985, Journal of molecular and cellular cardiology.
[26] J. Cohn,et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. , 1984, The New England journal of medicine.
[27] D. Harrison,et al. Study of the normal and failing isolated human heart: decreased response of failing heart to isoproterenol. , 1983, American heart journal.
[28] T. K. Harden,et al. Agonist-induced desensitization of the beta-adrenergic receptor-linked adenylate cyclase. , 1983, Pharmacological reviews.
[29] D C Harrison,et al. Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. , 1982, The New England journal of medicine.
[30] P. Molinoff,et al. Quantitative analysis of drug-receptor interactions: II. Determination of the properties of receptor subtypes. , 1981, Life sciences.
[31] H. R. Besch. Characterization of [3H](±)Carazolol Binding to β‐Adrenergic Receptors: Application to Study of β‐Adrenergic Receptor Subtypes in Canine Ventricular Myocardium and Lung , 1981, Circulation research.
[32] R. Taylor,et al. CARDIAC β‐ADRENORECEPTORS IN THE THYROXINE‐TREATED DOG , 1981 .
[33] Morris J. Brown,et al. Chronic heart failure in the guinea pig increases cardiac α1- and β-adrenoceptors , 1980 .
[34] D Rodbard,et al. Ligand: a versatile computerized approach for characterization of ligand-binding systems. , 1980, Analytical biochemistry.
[35] R. Lefkowitz,et al. A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled beta-adrenergic receptor. , 1980, The Journal of biological chemistry.
[36] T. K. Harden,et al. Catecholamine-specific desensitization of adenylate cyclase. Evidence for a multistep process. , 1980, The Journal of biological chemistry.
[37] H. Bourne,et al. Defect of receptor-cyclase coupling protein in psudohypoparathyroidism. , 1980, The New England journal of medicine.
[38] J. A. Thomas,et al. Plasma norepinephrine in congestive heart failure. , 1978, The American journal of cardiology.
[39] J. Peuler,et al. Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamine. , 1977, Life sciences.
[40] H. Bourne,et al. Selection of a variant lymphoma cell deficient in adenylate cyclase. , 1975, Science.
[41] C. Londos,et al. A highly sensitive adenylate cyclase assay. , 1974, Analytical biochemistry.
[42] D L Eckberg,et al. Defective cardiac parasympathetic control in patients with heart disease. , 1971, The New England journal of medicine.
[43] E. Braunwald,et al. Reduction of the Cardiac Response to Postganglionic Sympathetic Nerve Stimulation in Experimental Heart Failure , 1966 .
[44] E. Braunwald,et al. Mechanism of Norepinephrine Depletion in Experimental Heart Failure Produced by Aortic Constriction in the Guinea Pig , 1965, Circulation research.
[45] E. Braunwald,et al. CATECHOLAMINE EXCRETION AND CARDIAC STORES OF NOREPINEPHRINE IN CONGESTIVE HEART FAILURE. , 1965, The American journal of medicine.
[46] Oliver H. Lowry,et al. Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.
[47] S. Vatner,et al. Beta-receptors and adenylate cyclase: comparison of nonischemic, ischemic, and postmortem tissue. , 1990, The American journal of physiology.
[48] M. Caron,et al. Regulation of adenylyl cyclase-coupled beta-adrenergic receptors. , 1988, Annual review of cell biology.
[49] J. Cohn,et al. The autonomic nervous system in congestive heart failure. , 1986, Annual review of medicine.
[50] R. Kahn,et al. Antisera of designed specificity for subunits of guanine nucleotide-binding regulatory proteins. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[51] L. Jones,et al. Isolation of Canine Cardiac Sarcolemmal Vesicles , 1984 .